171 related articles for article (PubMed ID: 29335596)
1. Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy.
Jiao M; You HZ; Yang XY; Yuan H; Li YL; Liu WX; Jin M; Du J
Sci Rep; 2018 Jan; 8(1):724. PubMed ID: 29335596
[TBL] [Abstract][Full Text] [Related]
2. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
3. miR-454-3p and miR-194-5p targeting cardiac sarcolemma ion exchange transcripts are potential noninvasive diagnostic biomarkers for childhood dilated cardiomyopathy in Egyptian patients.
Fayez AG; Esmaiel NN; Salem SM; Ashaat EA; El-Saiedi SA; El Ruby MO
Egypt Heart J; 2022 Sep; 74(1):65. PubMed ID: 36076093
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
5. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
Vegter EL; Ovchinnikova ES; Silljé HHW; Meems LMG; van der Pol A; van der Velde AR; Berezikov E; Voors AA; de Boer RA; van der Meer P
PLoS One; 2017; 12(5):e0177242. PubMed ID: 28475616
[TBL] [Abstract][Full Text] [Related]
6. The Genetic Determination of the Differentiation Between Ischemic Dilated Cardiomyopathy and Idiopathic Dilated Cardiomyopathy.
Onrat ST; Onrat E; Ercan Onay E; Yalım Z; Avşar A
Genet Test Mol Biomarkers; 2018 Nov; 22(11):644-651. PubMed ID: 30346833
[TBL] [Abstract][Full Text] [Related]
7. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNAs as Potential Biomarkers for Celiac Disease Development.
Tan IL; Coutinho de Almeida R; Modderman R; Stachurska A; Dekens J; Barisani D; Meijer CR; Roca M; Martinez-Ojinaga E; Shamir R; Auricchio R; Korponay-Szabó IR; Castillejo G; Szajewska H; Koletzko S; Zhernakova A; Kumar V; Li Y; Visschedijk MC; Weersma RK; Troncone R; Mearin ML; Wijmenga C; Jonkers I; Withoff S
Front Immunol; 2021; 12():734763. PubMed ID: 34950132
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
[TBL] [Abstract][Full Text] [Related]
12. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
14. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
Abu-Halima M; Meese E; Keller A; Abdul-Khaliq H; Rädle-Hurst T
J Transl Med; 2017 Jul; 15(1):156. PubMed ID: 28693530
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy.
Zaragoza C; Saura M; Hernández I; Ramirez-Carracedo R; García-García F; Zamorano JL; Mangas A; Toro R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792263
[TBL] [Abstract][Full Text] [Related]
16. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.
Ozuynuk-Ertugrul AS; Ekici B; Erkan AF; Coban N
Lab Med; 2024 May; 55(3):361-372. PubMed ID: 38048807
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
18. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy.
Calderon-Dominguez M; Belmonte T; Quezada-Feijoo M; Ramos M; Calderon-Dominguez J; Campuzano O; Mangas A; Toro R
Sci Rep; 2021 Apr; 11(1):7517. PubMed ID: 33824379
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
Chen W; Li S
Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
[TBL] [Abstract][Full Text] [Related]
20. Postprandial Circulating miRNAs in Response to a Dietary Fat Challenge.
Mantilla-Escalante DC; López de Las Hazas MC; Gil-Zamorano J; Del Pozo-Acebo L; Crespo MC; Martín-Hernández R; Del Saz A; Tomé-Carneiro J; Cardona F; Cornejo-Pareja I; García-Ruiz A; Briand O; Lasunción MA; Visioli F; Dávalos A
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31200481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
